A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
Clinical trial NCT04397263 · COMPLETED
Trial details
- NCT number
- NCT04397263
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-10
- Primary completion
- 2024-02-29
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.